Initial Treatment of Autoimmune Adrenal Insufficiency
Most patients with autoimmune adrenal insufficiency require dual hormone replacement: hydrocortisone 15-25 mg daily in divided doses for glucocorticoid replacement plus fludrocortisone 50-200 µg daily for mineralocorticoid replacement. 1
Immediate Glucocorticoid Replacement
- Start hydrocortisone 15-25 mg daily in 2-3 divided doses (typically 10 mg upon waking, 5 mg at noon, and 2.5-5 mg in late afternoon, with the last dose at least 6 hours before bedtime) 1, 2
- Alternative regimens include 15+5 mg, 10+10 mg, or 10+5+5 mg depending on individual response 3
- For children, use 6-10 mg/m² of body surface area 1
- Cortisone acetate 18.75-31.25 mg daily (equivalent to 15-25 mg hydrocortisone) is an acceptable alternative 1
- Use the lowest dose compatible with health and sense of well-being 1
Essential Mineralocorticoid Replacement
- Start fludrocortisone 50-200 µg as a single daily dose 1, 4
- Children and younger adults typically require higher doses (up to 500 µg daily may be needed) 3
- Primary adrenal insufficiency requires both glucocorticoid AND mineralocorticoid replacement, unlike secondary adrenal insufficiency which only requires glucocorticoids 3
- Monitor adequacy by assessing for postural hypotension, salt cravings, serum sodium/potassium, and plasma renin activity 1
Critical Patient Education and Safety Measures
- All patients must wear medical alert identification jewelry and carry a steroid emergency card 1, 2
- Provide emergency injectable hydrocortisone 100 mg IM kit with self-injection training 3, 2
- Instruct patients to double or triple their glucocorticoid dose during minor illness with fever, vomiting, or physical stress 3, 2
- Educate on warning signs of adrenal crisis: severe weakness, confusion, abdominal pain, vomiting, profound hypotension 2
Stress Dosing Protocol
- Minor stress (fever, minor illness): Double the usual daily dose for 1-2 days 3
- Moderate stress: Hydrocortisone 50-75 mg daily or prednisone 20 mg daily 3
- Major stress (surgery, severe illness): Hydrocortisone 100 mg IM/IV before procedure, then 100 mg every 6-8 hours until recovery 3, 2
Screening for Associated Autoimmune Conditions
Continuous surveillance for other autoimmune disorders is mandatory because autoimmune adrenal insufficiency patients are at high risk of developing additional autoimmune diseases. 1
Annual Screening Requirements
- Thyroid function tests (TSH, free T4, TPO antibodies) every 12 months—hypothyroidism and thyrotoxicosis are frequently seen 1, 2
- Plasma glucose and HbA1c annually to screen for diabetes mellitus 1
- Complete blood count annually to screen for anemia 1
- Vitamin B12 levels annually due to common autoimmune gastritis 1
- Tissue transglutaminase antibodies and total IgA if frequent or episodic diarrhea occurs (screening for celiac disease) 1
- Counsel women of reproductive age about risk of premature ovarian insufficiency, especially if side-chain cleavage enzyme antibodies are present 1
Critical Pitfalls to Avoid
- Never start thyroid hormone replacement before adequate glucocorticoid replacement in patients with concurrent hypothyroidism—this can precipitate adrenal crisis 3, 2
- Never delay treatment of suspected adrenal crisis for diagnostic procedures—mortality increases with delayed intervention 1, 2, 5
- Do not rely on hyperkalemia to make the diagnosis—it is present in only ~50% of cases 3, 5
- Avoid liquorice and grapefruit juice as they interfere with hydrocortisone metabolism 1, 3
- If essential hypertension develops on fludrocortisone, reduce the dose but do not stop it 1
Follow-Up Monitoring
- Annual visits to assess symptoms, weight, blood pressure, and serum electrolytes 1, 2
- Evaluate for signs of under-replacement (fatigue, weight loss, hypotension, salt craving) or over-replacement (weight gain, hypertension, edema) 1, 2
- Consider morning cortisol day curve (baseline and 2,4,6 hours post-dose) if rapid cortisol disappearance is suspected 1
- Monitor bone mineral density every 3-5 years to assess for complications of glucocorticoid therapy 1